Article
Vitrification of mouse pronuclear oocytes with no direct liquid nitrogen contact

https://doi.org/10.1016/S1472-6483(10)60982-0Get rights and content

Abstract

The ability to routinely cryopreserve human oocytes and embryos represents a significant advancement in the field of assisted reproductive technology. Although the method of slow freezing is commonly employed, research on the alternative technique of vitrification is promising. Vitrification involves incubation of the cell in a cryoprotectant rich solution, which permits a glass-like state to occur almost instantaneously in liquid nitrogen. A number of different techniques have been invented for holding oocytes and embryos in the cryoprotectant solution during rapid vitrification and subsequent storage. Most of these involve direct contact with liquid nitrogen. Recently, concerns have been raised regarding the sterility of such a method and the potential of viral contamination from the liquid nitrogen. The present study shows that the previously reported Cryoloop method can be used to vitrify and store embryos without direct liquid nitrogen contact (during vitrification and storage). When such vitrified embryos are warmed, they are capable of subsequent development comparable with non-vitrified embryos.

Section snippets

Dr Mark Larman obtained his PhD, entitled ‘Calcium and MAP kinase regulation during the cell cycle’, in 2000 from the University of Newcastle upon Tyne, UK. He continued his interest in fertilization and the cell cycle by becoming part of the team that discovered the sperm protein that triggers oocyte activation (phospholipase C zeta). To apply and further his knowledge of mammalian fertilization and embryo development, he joined the research team at the Colorado Centre for Reproductive

References (34)

Cited by (32)

  • Vitrification of oocytes, embryos and blastocysts

    2012, Best Practice and Research: Clinical Obstetrics and Gynaecology
    Citation Excerpt :

    With recent improvements in past decades, vitrification has become the most reliable strategy because it is technically simple, and can lead to high survival and implantation rates. To induce vitrification in LN2, or super cooled air,8 the solution must contain a high concentration of CPA. This approach simplifies the cooling process, because embryos can be rapidly cooled directly in LN2.

  • Current results with slow freezing and vitrification of the human oocyte

    2011, Reproductive BioMedicine Online
    Citation Excerpt :

    While under experimental conditions, cross-contamination of cryopreserved reproductive cells has been reported (Bielanski et al., 2000), a recent review of this topic indicates that the actual contamination issue with open systems is not a practical concern when working under standard conditions used for assisted reproduction treatment and OCP (Pomeroy et al., 2010). Strategies to reduce any potential risk of contamination with open vitrification systems could include use of filtered or irradiated liquid nitrogen during the vitrification and/or storage process (Nagy et al., 2009a,b; Parmegiani et al., 2010) or vitrification and storage using nitrogen vapour versus liquid nitrogen (Cobo et al., 2010b; Eum et al., 2009; Larman et al., 2006). However, such approaches must balance the unproven risk of contamination under normal working conditions versus the risk of factors such as temperature fluctuations that could cause damage (Pomeroy et al., 2010).

  • Vitrification of mouse embryos with super-cooled air

    2011, Fertility and Sterility
    Citation Excerpt :

    It is worth noting that to date there have been no reports of human infection attributed to the use of contaminated cryostored germplasm; however, experimental conditions have shown that the potential still exists (19, 20). A proof-of-principle study by Larman et al. (21) demonstrated that the cryoloop can be used in a noncontact method by super-cooling the air inside the cryovial. Unfortunately, cryovials are not leak-proof during long-term storage in liquid nitrogen.

  • Vitrification of human oocytes and different development stages of embryos: An overview

    2010, Middle East Fertility Society Journal
    Citation Excerpt :

    A small nylon loop was attached to a holder and equipped with a container (Fig. 2). Using this tool, safe cryopreservation can be achieved even in the vapour of liquid nitrogen (38). Kuwayama et al. compared between the open system (cryotop) and the closed system (cryotip) over 13,000 embryos at different stages and suggested that cryotop is an efficient and reliable way to vitrify cleavage embryos, blastocysts and oocytes in daily practice (36).

  • IVM and gene expression of sheep cumulus - oocyte complexes following different methods of vitrification

    2010, Reproductive BioMedicine Online
    Citation Excerpt :

    Mammalian oocyte vitrification was first performed in 1958 (Sherman and Lin, 1958). Since then, many researchers have vitrified the oocytes of different species such as mouse (Larman et al., 2006), cow (Morato et al., 2008), sheep (Antinori et al., 2007; Bogliolo et al., 2007; Cobo et al., 2008) and human (Antinori et al., 2007) using different devices. In most vitrification techniques, the size of the oocyte-containing droplet is relatively large and its cooling rate may be lower than optimal because of the flotation on liquid nitrogen before submerging.

  • Aseptic vitrification of blastocysts from infertile patients, egg donors and after IVM

    2009, Reproductive BioMedicine Online
    Citation Excerpt :

    In view of the issues raised by this directive, it was imperative to revise this study centre’s ultra-rapid vitrification procedure (Vanderzwalmen et al., 2002, 2003) and to develop a new vitrification technique ensuring total protection and isolation of the sample from the liquid nitrogen during the cooling procedure as well as during long-term storage. Hermetically closed containers (closed systems) have already been developed to vitrify mice and human oocytes and embryos (Kuleshova and Shaw, 2000; Walker et al., 2004; Isachenko et al., 2005, 2007; Kuwayama et al., 2005; Larman et al., 2006; Stachecki et al., 2008). Kuwayama et al. (2005) developed the Cryotip device, allowing isolation of biological material from liquid nitrogen.

View all citing articles on Scopus

Dr Mark Larman obtained his PhD, entitled ‘Calcium and MAP kinase regulation during the cell cycle’, in 2000 from the University of Newcastle upon Tyne, UK. He continued his interest in fertilization and the cell cycle by becoming part of the team that discovered the sperm protein that triggers oocyte activation (phospholipase C zeta). To apply and further his knowledge of mammalian fertilization and embryo development, he joined the research team at the Colorado Centre for Reproductive Medicine in 2004. His main interests include vitrification and developing oocyte/embryo viability assays.

View full text